Giray Semih, Ozdemir Ozcan, Baş Demet F, İnanç Yusuf, Arlıer Zulfikar, Kocaturk Ozcan
Gaziantep University, Medical Faculty, Department of Neurology, Interventional Neurology, Turkey.
Eskisehir Osmangazi University, Medical Faculty, Department of Neurology, Neurocritical Care, Cerebrovascular Disease, Interventional Neurology, Eskisehir, Turkey.
J Neurol Sci. 2017 Jan 15;372:104-109. doi: 10.1016/j.jns.2016.11.006. Epub 2016 Nov 10.
The goal of the study was to identify whether the stroke etiology play a role in the recanalization and outcome of patients who underwent mechanical thrombectomy with stent retrievers.
A retrospective analysis of a prospectively collected database included consecutive patients treated with stent retrievers. We included patients with cardioembolic stroke and large vessel atherosclerotic disease and compared risk factors for stroke, baseline NIHSS and Alberta Stroke Program Early CT scores (ASPECTS), stroke outcome, recanalization rate, onset-to-recanalization, onset-to-groin puncture time and the procedural time between two groups. Male sex was statistically more common in patients with large vessel atherosclerotic disease. Mean time from symptom onset- to the achievement of recanalization in patients with LVAD was 242±72.4 compared with cardioembolic stroke patients (301±70.7; p=0.014). Time for groin puncture to recanalization was longer in patients with cardioembolic stroke compared to LVAD group (97.5±44.3 vs 58.2±21.8; p=0.002). Time for microcatheter to successful recanalization or procedural termination was longer in patients with cardioembolic stroke compared to LVAD group (63.6±30.2 vs 34.2±19.4; p<0.001) with cardioembolic stroke had significantly worse long-term outcome (mRS 3-6) compared to those with LVAD (60.6% vs 26.3%; p=0.036).
Stroke etiology may play a role in the outcome of acute stroke patients who underwent endovascular stroke therapy. Cardioembolic strokes may be more resistant to endovascular acute stroke treatment.
本研究的目的是确定卒中病因是否在接受支架取栓器机械取栓的患者的再通情况及预后中发挥作用。
对前瞻性收集的数据库进行回顾性分析,纳入连续接受支架取栓器治疗的患者。我们纳入了心源性栓塞性卒中和大动脉粥样硬化性疾病患者,并比较了两组患者的卒中危险因素、基线美国国立卫生研究院卒中量表(NIHSS)评分和阿尔伯塔卒中项目早期CT评分(ASPECTS)、卒中结局、再通率、发病至再通时间、发病至股动脉穿刺时间以及手术时间。大动脉粥样硬化性疾病患者中男性在统计学上更为常见。左心室辅助装置(LVAD)患者从症状发作到实现再通的平均时间为242±72.4,而心源性栓塞性卒中患者为(301±70.7;p=0.014)。与LVAD组相比,心源性栓塞性卒中患者从股动脉穿刺到再通的时间更长(97.5±44.3对58.2±21.8;p=0.002)。与LVAD组相比,心源性栓塞性卒中患者从微导管插入到成功再通或手术终止的时间更长(63.6±30.2对34.2±19.4;p<0.001),心源性栓塞性卒中患者的长期预后(改良Rankin量表评分3 - 6分)明显比LVAD患者差(60.6%对26.3%;p=0.036)。
卒中病因可能在接受血管内卒中治疗的急性卒中患者的预后中发挥作用。心源性栓塞性卒中可能对血管内急性卒中治疗更具抵抗性。